Oxford BioMedica (OTC:OXBDF) Stock, Quote.Headers.trade-ideas

Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types.

Biotech

Large Cap

News

Penny Stocks

Health Care

Financing

Offerings

Small Cap

Management

General

AKBA

AZNCF

ENDP

GILD

GMAB

NKTR

NRXP

OTSKF

OTSKY

OXBDF

PRVB

XFOR

Here&#39;s a roundup of top developments in the biotech space over the last 24 hours:

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

$BTC

$ETH

AAPL

AMZN

BNPQY

DINO

FTCV

GOOG

GOOGL

HYMTF

SEAC

SZKMY

TSLA

CNBC

Why Kohl’s Shares Are Plunging Today

Benzinga Before The Bell: Kohl&#39;s Deal Talks Cancellation, Tesla&#39;s Racial Discrimination Lawsuit, Nio&#39;s Strong June Deliveries And Other Top Financial Stories Friday, July 1

Contracts

Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca&#39;s COVID-19 Vaccine

OXFORD BIOMEDICA PLC NEW by Oxford Biomedica PLC

Oxford BioMedica PLC

Oxford BioMedica

Comments

Oxford BioMedica

Oxford BioMedica (OTC:OXBDF) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell